Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients
trial results.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -10.55% | -42.65% |
1st Jan change | Capi. | |
---|---|---|
-42.65% | 29.84M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |